Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma

Table 2

Clinicopathological characteristics of FUSCC PDAC patients stratified by MUC2 expression.

Variables	MUC2 negative	MUC2 positive
Age, (%)			0.905
<62	167 (47.0%)	33 (47.8%)
≥62	188 (53.0%)	36 (52.2%)
Sex, (%)			0.760
Male	201 (57.4%)	41 (59.4%)
Female	149 (42.6%)	28 (40.6%)
Tumour grade, (%)			0.171
Low	13 (3.7%)	6 (8.7%)
Moderate	214 (61.3%)	38 (55.1%)
High	122 (35.0%)	25 (36.2%)
Tumour stage, (%)			0.699
I	143 (40.3%)	26 (37.7%)
II	167 (47.0%)	36 (52.2%)
III	45 (12.7%)	7 (10.1%)
T stage, (%)			0.730
T1	64 (18.0%)	10 (14.5%)
T2	204 (57.5%)	40 (58.0%)
T3	87 (24.5%)	19 (27.5%)
N stage, (%)			0.746
N0	182 (52.0%)	33 (47.8%)
N1	130 (37.1%)	29 (42.0%)
N2	38 (10.9%)	7 (10.1%)
Tumour location, (%)			0.407
Head	191 (54.6%)	39 (56.5%)
Body	158 (45.1%)	29 (42.0%)
Tail	1 (0.3%)	1 (1.4%)
Vascular invasion, (%)			0.830
No	92 (26.3%)	19 (27.5%)
Yes	258 (73.7%)	50 (72.5%)
Perineural infiltration, (%)			0.030
No	312 (89.1%)	55 (79.7%)
Yes	38 (10.9%)	14 (20.3%)
Diabetes mellitus, (%)			0.174
No	297 (84.9%)	54 (78.3%)
Yes	53 (15.1%)	15 (21.7%)